Exploring NASDAQ:MEDP's growth characteristics.

In this article we will dive into MEDPACE HOLDINGS INC (NASDAQ:MEDP) as a possible candidate for growth investing. Investors should always do their own research, but we noticed MEDPACE HOLDINGS INC showing up in our CANSLIM growth screen, which makes it worth to investigate a bit more.

What matters for canslim investors.

• The earnings per share (EPS) of MEDPACE HOLDINGS INC have shown positive growth on a quarter-to-quarter (Q2Q) basis, with a 32.19% increase. This reflects the company's ability to improve its profitability over time.
• MEDPACE HOLDINGS INC has demonstrated strong q2q revenue growth of 31.22%, suggesting a favorable trend in the company's financials and indicating the potential for continued expansion.
• The 3-year EPS growth of MEDPACE HOLDINGS INC (34.48%) highlights the company's ability to consistently improve its earnings performance and suggests a positive outlook for future profitability.
• MEDPACE HOLDINGS INC exhibits a strong Return on Equity (ROE) of 68.65%, indicating the company's ability to generate solid returns on shareholder investments. This metric reflects the company's efficient utilization of equity capital and its profitability.
• MEDPACE HOLDINGS INC has achieved an impressive Relative Strength (RS) rating of 94.6, showcasing its ability to outperform the broader market. This strong performance positions MEDPACE HOLDINGS INC as an attractive stock for potential price appreciation.
• MEDPACE HOLDINGS INC maintains a healthy Debt-to-Equity ratio of 0.0. This indicates the company's conservative capital structure and signifies its ability to effectively manage debt obligations while maintaining a strong equity position.
• The ownership composition of MEDPACE HOLDINGS INC reflects a balanced investor ecosystem, with institutional shareholders owning 77.25%. This indicates a broader market participation and potential for increased trading liquidity.

Technical analysis of NASDAQ:MEDP

ChartMill utilizes a proprietary algorithm to assign a Technical Rating to every stock. This rating, ranging from 0 to 10, is computed daily by analyzing a variety of technical indicators and properties.

We assign a technical rating of 10 out of 10 to MEDP. This is due to a consistent performance in both the short and longer term time frames. Also compared to the overall market, MEDP is showing a nice and steady performance.

• Both the short term and long term trends are positive. This is a very positive sign.
• When comparing the yearly performance of all stocks, we notice that MEDP is one of the better performing stocks in the market, outperforming 94% of all stocks. We also observe that the gains produced by MEDP over the past year are nicely spread over this period.
• MEDP is one of the better performing stocks in the Life Sciences Tools & Services industry, it outperforms 95% of 63 stocks in the same industry.
• MEDP is currently trading near its 52 week high, which is a good sign. The S&P500 Index is trading in the upper part of its 52 week range, but not near new highs, so MEDP is leading the market.
• In the last month MEDP has a been trading in the 230.00 - 269.44 range, which is quite wide. It is currently trading near the high of this range.

Check the latest full technical report of MEDP for a complete technical analysis.

Fundamental Analysis Observations

As part of its analysis, ChartMill provides a comprehensive Fundamental Rating for each stock. This rating, ranging from 0 to 10, is updated on a daily basis and is based on the evaluation of various fundamental indicators and properties.

MEDP gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 63 industry peers in the Life Sciences Tools & Services industry. Both the health and profitability get an excellent rating, making MEDP a very profitable company, without any liquidiy or solvency issues. MEDP is not priced too expensively while it is growing strongly. Keep and eye on this one! This makes MEDP very considerable for growth and quality investing!

For an up to date full fundamental analysis you can check the fundamental report of MEDP

Our CANSLIM screen will find you more ideas suited for growth investing.

Disclaimer

This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.